Related Experiment Videos
Cryosurgery for prostate cancer
1Medical University of South Carolina, Charleston, South Carolina, USA.
Archives of Andrology
|August 2, 2003
Summary
Cryosurgical ablation of the prostate (CSAP) is an effective treatment for prostate cancer, with newer equipment showing promise. Further research is needed, but CSAP may play a significant role in future prostate cancer management.
Area of Science:
- Urology
- Oncology
- Surgical Technology
Background:
- Prostate cancer management choices depend on patient and disease factors.
- Cryosurgical ablation of the prostate (CSAP) is an evolving treatment option.
- Advancements in cryosurgical equipment have improved safety and efficiency.
Purpose of the Study:
- To evaluate the effectiveness and safety of cryosurgical ablation of the prostate (CSAP) in managing prostate cancer.
- To assess the role of third-generation cryosurgical equipment in prostate cancer treatment.
Main Methods:
- CSAP performed under continuous ultrasonic monitoring.
- Procedures conducted in ambulatory or inpatient settings.
- Analysis of data from second-generation and early data from third-generation cryosurgical equipment.
Main Results:
- Mature data indicate CSAP is effective with second-generation equipment.
- Early responses with third-generation equipment are favorable.
- CSAP demonstrates a good side effect profile.
Conclusions:
- CSAP is a viable therapeutic modality for prostate cancer.
- Third-generation cryosurgical equipment shows potential for a prominent role in prostate cancer management.
- Continued research will further define CSAP's role.